← ALL FRONTIERS
// FRONTIER.CHEATING-DEATH

Cheating Death

Longevity & Age-Reversal

8 companies · 8 sourced backers · 39 milestones on record

// What this frontier is about

Longevity and age-reversal research aims to extend healthy life by understanding aging and developing ways to prevent or treat age-related disease. Companies are exploring medicines that restore aged cells and tissues, alongside using genomic and other health information to identify and manage risks earlier.

// How real is it?

Where the 8 companies stand today, from their profiles and 10-year milestones. Tap a phase to see who is there.

← labavailable to all →
// What usually holds it back
  • ▸Turning fundamental aging research into usable medicines
  • ▸Demonstrating benefits in human clinical trials
  • ▸Moving experimental therapies toward approval
  • ▸Making health information useful for preventive care
// Who's backing it
Founders Fund· NewLimitThrive CapitalGreenoaksQuiet CapitalKleiner PerkinsEli Lilly Ventures4P CapitalSam Altman

Publicly listed: 1 company (owned by public shareholders).

// Inside the terminal
  • ›Every sourced story on all frontiers, filterable by company and news type
  • ›10-year milestone records for each company: demo vs shipped
  • ›Explained: plain-words readiness diagrams for real breakthroughs
  • ›Signal Trends of 39 frontiers covering 378 companies over time.
  • ›The events calendar: launches, approvals and deadlines ahead
Create a free account
// Companies in this frontier
  • Altos Labs

    Full success would mean turning cellular rejuvenation into approved medicines that can restore cell health and treat or reverse age-related disease in patien…

    Lab

  • BioAge Labs

    To develop a broad pipeline of therapies that target the biology of aging itself, extending the number of years people live in good health.

    Lab · publicly listed

  • Calico Life Sciences

    Full success would mean turning fundamental discoveries about why we age into approved therapies that prevent or treat age-related diseases — a long-horizon …

    Lab

  • Gilgamesh Pharmaceuticals

    Full success would mean a new class of fast-acting, durable psychiatric medicines that treat depression and related disorders far better than today's antidep…

    Lab

  • Human Longevity Inc.

    To use genomic and other health information to support preventive, personalised care.

    Some users

  • Life Biosciences

    Full success would mean a platform that reverses cellular aging to restore function in diseased tissues — beginning with vision restoration — moving from its…

    Lab

  • NewLimit

    Full success would mean medicines that restore youthful function to aged cells and tissues, adding healthy years to human life — a goal NewLimit is pursuing …

    Lab · backed by Founders Fund

  • Retro Biosciences

    The company's stated mission is to extend healthy human lifespan by 10 years by bringing therapies that reverse age-related disease through clinical trials t…

    Lab

// WEEKLY.UPDATES

Keep following breakthroughs like these. Every Monday, get up to 5 major breakthroughs and launches explained in plain English.

Free. No account needed. One email a week. Unsubscribe anytime.

12 NOV 2026

BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates

11 NOV 2026

BioAge Labs unveils full Phase 1 data for BGE-102 oral NLRP3 inhibitor in healthy volunteers and obesity patients

5 NOV 2026

BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates

22 OCT 2026

Calico Life Sciences Announces European Medicines Agency Grants PRIME Designation to Investigational Fosigotifator for Vanishing White Matter

21 OCT 2026

Global Longevity BioTech Market Size and Forecast Report 2026-2030 | Capitalize on 10.7% CAGR as Insilico Medicine, Calico, and Altos Labs Lead the Industry